Bioequivalence of 20-mg once-daily Tamoxifen relative to 10-mg twice-daily Tamoxifen regimens for breast cancer
medrev 2017-04-26T12:34:59+00:00Abstract PURPOSE: We studied the bioequivalence of a new once-daily regimen of tamoxifen citrate relative to the standard twice-daily regimen of tamoxifen citrate, an established antiestrogenic treatment for breast cancer. PATIENTS AND METHODS: Of 30 women with breast cancer, 27 completed this open, two-period, crossover randomized trial. During one 3-month period, patients took one standard [...]
